137 related articles for article (PubMed ID: 14721789)
1. Severe nail changes due to Docetaxel treatment.
Rafi L; Friedrich M; Tilgen W; Reichrath J
Eur J Dermatol; 2003; 13(6):610-1. PubMed ID: 14721789
[TBL] [Abstract][Full Text] [Related]
2. [Onycholysis due to docetaxel in breast cancer treatment].
Grasland A; Grandjean M; Rist S; Bosquet A; Vinceneux P
Rev Med Interne; 2005 May; 26(5):427-8. PubMed ID: 15893036
[No Abstract] [Full Text] [Related]
3. Chemotherapy-induced nail changes: an unsightly nuisance.
Marrs J; Newton S
Clin J Oncol Nurs; 2004 Oct; 8(5):527-8. PubMed ID: 15515285
[No Abstract] [Full Text] [Related]
4. Nail toxicity related to taxanes.
Mourad YA; Matta-Muallem M; Shamseddine A
Dermatol Online J; 2003 Aug; 9(3):15. PubMed ID: 12952762
[TBL] [Abstract][Full Text] [Related]
5. Nail changes secondary to docetaxel (Taxotere).
Correia O; Azevedo C; Pinto Ferreira E; Braga Cruz F; Polónia J
Dermatology; 1999; 198(3):288-90. PubMed ID: 10393455
[TBL] [Abstract][Full Text] [Related]
6. Docetaxel chemotherapy induces transverse superficial loss of the nail plate.
Llombart-Cussac A; Pivot X; Spielmann M
Arch Dermatol; 1997 Nov; 133(11):1466-7. PubMed ID: 9371043
[No Abstract] [Full Text] [Related]
7. Taxane-induced nail changes: Predictors and efficacy of the use of frozen gloves and socks in the prevention of nail toxicity.
Can G; Aydiner A; Cavdar I
Eur J Oncol Nurs; 2012 Jul; 16(3):270-5. PubMed ID: 21784705
[TBL] [Abstract][Full Text] [Related]
8. Lymphocutaneous nocardiosis in a lymphopenic breast cancer patient under treatment with docetaxel.
Apostolakis S; Chalkiadakis I; Ventouri M; Maraki S; Tsoussis S
Breast J; 2005; 11(6):469. PubMed ID: 16297095
[No Abstract] [Full Text] [Related]
9. Docetaxel-related skin, nail, and vascular toxicity.
Leonard GD; Zujewski JA
Ann Pharmacother; 2003 Jan; 37(1):148. PubMed ID: 12564432
[No Abstract] [Full Text] [Related]
10. Clinical picture: nail changes secondary to docetaxel.
Wasner G; Hilpert F; Baron R; Pfisterer J
Lancet; 2001 Mar; 357(9260):910. PubMed ID: 11289346
[No Abstract] [Full Text] [Related]
11. Docetaxel-induced subungual hemorrhage.
Vanhooteghem O; André J; Vindevoghel A; Vandenbossche L; Vandeveire A; Song M
Dermatology; 1997; 194(4):419-20. PubMed ID: 9252781
[TBL] [Abstract][Full Text] [Related]
12. Nail changes during docetaxel containing combination chemotherapy.
Woo IS; Shim KH; Kim GY; Lee MA; Kang JH; Hong YS; Lee KS
Korean J Intern Med; 2004 Jun; 19(2):132-3. PubMed ID: 15366647
[TBL] [Abstract][Full Text] [Related]
13. Nail changes due to docetaxel.
Pavithran K; Doval DC
Br J Dermatol; 2002 Apr; 146(4):709-10. PubMed ID: 11966714
[No Abstract] [Full Text] [Related]
14. Taxane-induced nail changes: incidence, clinical presentation and outcome.
Minisini AM; Tosti A; Sobrero AF; Mansutti M; Piraccini BM; Sacco C; Puglisi F
Ann Oncol; 2003 Feb; 14(2):333-7. PubMed ID: 12562663
[TBL] [Abstract][Full Text] [Related]
15. Matched case-control phase 2 study to evaluate the use of a frozen sock to prevent docetaxel-induced onycholysis and cutaneous toxicity of the foot.
Scotté F; Banu E; Medioni J; Levy E; Ebenezer C; Marsan S; Banu A; Tourani JM; Andrieu JM; Oudard S
Cancer; 2008 Apr; 112(7):1625-31. PubMed ID: 18286527
[TBL] [Abstract][Full Text] [Related]
16. Nail bed dyschromia secondary to docetaxel therapy.
Jacob CI; Patten SF
Arch Dermatol; 1998 Sep; 134(9):1167-8. PubMed ID: 9762045
[No Abstract] [Full Text] [Related]
17. Multicenter study of a frozen glove to prevent docetaxel-induced onycholysis and cutaneous toxicity of the hand.
Scotté F; Tourani JM; Banu E; Peyromaure M; Levy E; Marsan S; Magherini E; Fabre-Guillevin E; Andrieu JM; Oudard S
J Clin Oncol; 2005 Jul; 23(19):4424-9. PubMed ID: 15994152
[TBL] [Abstract][Full Text] [Related]
18. Onycholysis in patients treated with docetaxel.
Obermair A; Binder M; Barrada M; Bancher-Todesca D; Asseryanis E; Kubista E
Ann Oncol; 1998 Feb; 9(2):230-1. PubMed ID: 9553674
[No Abstract] [Full Text] [Related]
19. [Yellow nails].
Auvinet M; Dahan S; Dingremont C; Ollier S; Juchet H; Arlet P
Rev Med Interne; 1998 May; 19(5):353-4. PubMed ID: 9775172
[No Abstract] [Full Text] [Related]
20. Docetaxel-induced onycholysis: the role of subungual hemorrhage and suppuration.
Roh MR; Cho JY; Lew W
Yonsei Med J; 2007 Feb; 48(1):124-6. PubMed ID: 17326255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
